Download our SARS-CoV-2 Poster
or request a physical copy.
At each and every step of your workflow, we want to be able to disrupt and dismantle the SARS-CoV-2 virus. This means understanding the functions of the proteins encoded by the virus genome, and the host entry points and pathways it utilizes. It means discerning effective immune responses in COVID-19 patients and disease models. And it means discovering new biomarkers and pathways for therapeutic treatments, vaccine candidates, and viral detection kits. We've organized our diverse products (antibodies, recombinant proteins, cytokine detection kits, and proteogenomics profiling options) by workflow stages, making it easier to pick your reagents and start your experiments. Browse our informative videos on COVID-19. Read our blog on the importance of highly sensitive and quantitative ELISAs to measure antibodies raised against SARS-CoV-2 so that we better understand the status of protective immunity in our population.
If you are working with whole blood from samples vaccinated against COVID-19, please read through our FAQ in the General Flow Cytometry section to learn how this could affect staining.
BioLegend wants to help in your fight against COVID-19
BioLegend is dedicated to helping accelerate the development of diagnostic tests, therapeutics, and vaccines for SARS-CoV-2. If you would like BioLegend to review a potential partnership or a collaboration for your research, please tell us how we can support your work and provide us with a projected timeline.